Clinical Trials Auditing

Observing and evaluating of clinical preliminaries is important to guarantee that the:

  • Rights and security of patients (i.e., human subjects) are ensured 
  • Reported   preliminary  information  are exact, finished, and detailed preliminary information are precise, finished, and evident from source records. 
  • Conduct of preliminary is in consistence with convention, great clinical practice (GCP) and relevant administrative prerequisites. 
  • When leading an IND preliminary, the guidelines require the support to screen the investigation.

Sub Tracks:

  • Informed Consent Process & Documentation
  • Accurate and Complete Study Records
  • Determination and Documentation that eligibility criteria are satisfied
  • Adverse Event review and reporting
  • Closure of study or lapse in approvals while study related activities are still ongoing.
  • Drug/Device accountability
  • Protocol adherence
  • Poor regulatory site documentation
  • Failure to address monitor findings

Clinical Study Designs Conferences Translational Clinical Research Conferences Regulatory Affairs Conferences Medical Case Reports Conferences Clinical Trails Conferences 2020 Canada Oncology Clinical Trials Conferences Clinical Research Conferences 2020 Clinical Trials Auditing Conferences Clinical Trails Conferences 2020 Clinical Research Conferences